Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
accused, ACTR, advocacy, Affimed, alloSCT, altogether, Appeal, art, attack, azacitidine, Baker, Bipartisan, book, branded, bribery, carboplatin, cellular, choose, chromosome, clear, clearance, concurrently, CR, CRi, curb, cytoreduction, decide, decitabine, denintuzumab, dismal, dismissed, disproportionate, District, edema, embolism, encompassing, enfortumab, etoposide, facilitate, feasible, foregoing, formulation, fragile, frail, frame, freely, grew, HL, ifosfamide, immigration, immunological, inadequacy, indefinitely, inhibitor, injection, insignificant, instability, interact, IPR, Italy, Karyopharm, Kingdom, licensee, light, living, LP, mafodotin, MEI, merit, modest, molecule, myelodysplastic, owner, passage, pembroluzimab, perception, pharmacodynamic, Philadelphia, pre, prevailing, properly, PTAB, purport, Radiological, RCHP, repatriated, resale, RICE, scrutinize, settle, talirine, timeline, trastuzumab, treble, unavailability, undergo, unremitted, unrest, Unum, upcoming, USPTO, vadastuximab, valuable, venetoclax
Removed:
advisor, affinity, alternating, Anatomy, characterize, commenced, Condensed, consumed, convened, defucosylation, demonstrating, direct, durable, exclusively, Genome, IDEC, lowered, mid, myeloma, NDA, OBT, Oncovin, Oxford, pediatric, placebo, pool, prevalence, propriety, refuse, represented, sBLA, screened, UK, unconjugated, week, Wyeth
Filing tables
Filing exhibits
Related press release
SGEN similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements onForm S-8 (Nos. 333-56670, 333-148188,333-168672, 333-176144, 333-188446, 333-197992, and 333-204331) of Seattle Genetics, Inc., and the Registration Statement onForm S-3 (No. 333-206846) of Seattle Genetics, Inc., of our report dated February 19, 2016 relating to the consolidated financial statements and the effectiveness of internal control over financial reporting, which appears in thisForm 10-K.
/s/ PricewaterhouseCoopers LLP
Seattle, Washington
February 19, 2016